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Abstract
Type 2 diabetes is a major public health problem in the USA, affecting over 12 % of American 
adults and imposing considerable health and economic burden on individuals and society. There is 
a strong evidence base demonstrating that lifestyle behavioral changes and some medications can 
prevent or delay the onset of type 2 diabetes in high risk adults, and several policy and healthcare 
system changes motivated by the Patient Protection and Affordable Care Act (ACA) have the 
potential to accelerate diabetes prevention. In this narrative review, we (1) offer a conceptual 
framework for organizing how the ACA may influence diabetes prevention efforts at the level of 
individuals, healthcare providers, and health systems; (2) highlight ACA provisions at each of 
these levels that could accelerate type 2 diabetes prevention nationwide; and (3) explore possible 
policy gaps and opportunity areas for future research and action.
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Introduction
Type 2 diabetes is a major public health problem in the USA, affecting over 12 % of adults 
and imposing considerable health and economic burden on individuals and society [1, 2]. 
Because obesity, dietary composition, and physical inactivity are key drivers of the 
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development of type 2 diabetes, it is largely a socially and environmentally determined 
condition and is preventable [3, 4]. Preventing diabetes will require interventions at multiple 
levels, spanning public policy to individual counseling [5–7], all ultimately aligned to 
encourage and enable healthier lifestyle behaviors that can reduce harmfully elevated blood 
glucose levels [8, 9].
In the USA today, 86 million Americans, or more than one in three adults have been 
classified as having “prediabetes,” a condition characterized by blood sugar levels that are 
higher than normal but not high enough to be considered diabetes [1]. Approximately 5–
10 % of people with prediabetes develop diabetes each year, and 70 % will do so during 
their lifetime [10, 11]. Diabetes is a considerable threat to population health, spares no 
segment of society, and disproportionately affects the poor, the aged, and racial and ethnic 
minorities [1, 12]. Given these staggering statistics, primary prevention is critical to reduce 
the future population burden of diabetes.
A large body of research demonstrates the role that health services and individual behavior 
can play in preventing diabetes among adults with prediabetes [13–16]. The US Diabetes 
Prevention Program (DPP) clinical trial and subsequent translational studies have 
demonstrated that intensive lifestyle interventions focused on achieving 7 % weight loss and 
at least 150 min per week of moderate physical activity can cut the risk of developing 
diabetes in half [8, 17]. Such interventions also improve health-related quality of life [18], 
enable some patients to reduce the need for medications [19], and may lower future 
healthcare expenditures [10, 20, 21]. The DPP and other trials also found that metformin, a 
medication often used to treat diabetes, as well as other select medications, are efficacious 
treatments for preventing diabetes [8, 14]. While past research has demonstrated that the 
benefits of lifestyle interventions and metformin begin within 3 to 6 months and can last for 
more than a decade [8, 22], the delivery of these individual interventions are alone not 
sufficient for diabetes prevention at the population level [3, 23, 24*].
Policy, systems, and environmental changes (PSE) are also essential elements of a long-term 
agenda to prevent chronic diseases like diabetes [7, 25, 26]. Policies and environmental 
changes function to make healthy behaviors more accessible or desirable and unhealthy 
exposures more difficult or even prohibited. System-level interventions aim to improve the 
functioning of an agency or organization, as well as the delivery of its services to the 
community. The Patient Protection and Affordable Care Act (ACA) [27] represents a 
collection of PSE interventions creating many opportunities to accelerate diabetes 
prevention on a national scale [27–30]. Through a simultaneous focus on individuals, 
healthcare providers, health systems, and community resources, the ACA targets multiple 
levels of influence—an approach widely advocated by public health authorities for tackling 
diabetes prevention at scale [6, 31].
While some prior reports have described how the ACA may impact national diabetes 
prevention efforts [28–30, 32], they were written prior to the law’s full implementation and 
would benefit from an update. Recent reports have also highlighted a gap in high-quality 
research to evaluate diabetes prevention policies [5, 33, 34]. for these reasons, we conducted 
a narrative review to (1) offer a conceptual framework for organizing how the ACA may 
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influence diabetes prevention efforts at the level of individuals, healthcare providers, and 
health systems; (2) highlight ACA provisions at each of these levels that could accelerate 
type 2 diabetes prevention nationwide; and (3) explore possible policy gaps and opportunity 
areas for future research and action.
Methods
Our review began with an electronic search of PubMed and Google Scholar, combining 
MeSH headings and keywords related to diabetes (i.e., “diabetes mellitus,” “prediabetic 
state,” “diabetes prevention,” OR “prevention of diabetes”) along with terms relating to 
policy actions (i.e., “Patient Protection and Affordable Care Act,” “ACA,” OR “policy”). 
Articles published during or after 2010, the year the ACA became law, were considered, 
with no other explicit inclusion or exclusion criteria. Because of our goal to describe the 
broad state of policy actions, we did not restrict the literature search on whether an 
evaluation had already taken place or if that evaluation met particular criteria for 
methodological rigor.
Titles of all identified reports were reviewed for their relevance, and full manuscripts for all 
relevant reports were retrieved and reviewed. Two authors also reviewed and summarized 
relevant provisions from the ACA. We then reached out to expert stakeholders at relevant 
agencies or organizations, such as the Centers for Disease Control and Prevention (CDC), 
the Centers for Medicare and Medicaid Services (CMS), the US Department of Health and 
Human Services (HHS), the American Medical Association (AMA), and the American 
Diabetes Association (ADA) to request further descriptions.
Our search did not identify any prior systematic reviews or strong research studies directly 
relating healthcare-focused policy and systems interventions with the prevention of type 2 
diabetes. Given this evidence gap, we elected to propose a framework for organizing how 
ACA interventions might prevent type 2 diabetes. We used an iterative process of group 
discussion and mapping of relevant policy domains to the framework and developed a 
narrative to highlight key findings, gaps, and implications identified from all relevant data 
sources.
Discussion
Diabetes Prevention Care Continuum Framework
Given a strong evidence base demonstrating that lifestyle behavioral changes and some 
medications prevent or delay the onset of type 2 diabetes in high risk adults [13–16], we 
elected to organize the conceptual framework primarily to depict how healthcare policy and 
system changes could support or enable those behaviors, particularly among high-risk 
individuals. Conceptually, PSE addressing broader domains such as community safety, 
healthy food access, or the creation of environments to support physical activity are also 
likely to achieve type 2 diabetes prevention on a larger scale, but are beyond the scope of 
this review. Readers are directed to past reports that focus more specifically on these broader 
areas [4, 35–37].
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The framework conceptualizes preventive behaviors as emerging from more supportive 
environments, social support systems, or participation in evidence-based interventions 
targeting individuals or small groups. Because the current economic, social, cultural, and 
physical environment in the USA is not sufficiently supportive of behaviors that prevent 
obesity or type 2 diabetes [37], the ACA targets the health system and its interface with 
community and public health systems, as vehicles for affecting behavioral change.
However, when the broader environment is largely unsupportive, behavioral change requires 
individuals to be aware, motivated, and strongly supported. Current recommendations for 
raising individual awareness of diabetes risk require testing of blood glucose or hemoglobin 
A1c within the health system [38]. For this reason, the ACA attempts to expand access to 
prepared and proactive healthcare personnel and services to enable risk assessment, the 
raising of awareness, and access to supportive interventions at individual, system, and 
community levels. This continuum is depicted in Fig. 1 and described further below.
Affordable Care Act and its Effect on the Diabetes Prevention Care Continuum
Access to Health Care—Access to health care is a multidimensional concept, including 
availability, organization, financing, utilization, and satisfaction [39]. Several provisions in 
the ACA extend healthcare access to millions of Americans through expansions of health 
insurance coverage and accessibility to healthcare providers (Table 1). Importantly, because 
many chronic conditions such as diabetes disproportionally affect certain population 
subgroups, such as racial/ethnic minorities and those facing socioeconomic disadvantage, 
several ACA provisions were also designed to ensure that these groups have equitable access 
to health insurance coverage and to a patient-centered medical home where they can receive 
evidence-based preventive services at low or no cost.
Insurance Coverage—One of the central goals of the ACA was to expand insurance 
coverage to eligible Americans who previously lacked health insurance. Pursuant to the 
ACA, the US Department of Health and Human Services reported a 35 % decrease in the 
number of uninsured adults between 2012 and the first quarter of 2015 [40]. Among the 
many provisions contributing to this effort, the ACA established the insurance marketplace 
(“exchanges”), which gives individuals the option of purchasing private qualifying health 
insurance plans independent of an employer. Early reports indicate that the ACA was 
successful in decreasing the number of Americans who have unpaid medical bills and those 
who report delaying care because of cost [41]. Additionally, the ACA’s expansion of 
Medicaid in several states increased eligibility to those at or below 138 % of the poverty 
level, a particularly vulnerable population. One recent report concluded that in states where 
Medicaid was expanded, there was a 23 % increase in the identification of diabetes [42*]. 
Though rates of newly identified prediabetes were not reported, both diabetes and 
prediabetes are detected using the same blood tests, so it is likely that identification of 
prediabetes has also increased by these coverage expansions. This increase in the diagnosis 
of diabetes is consistent with the findings from the pre-ACA Oregon Medicaid expansion in 
2008, where Medicaid coverage significantly increased diabetes detection by 3.83 
percentage points (95% CI 1.93 to 5.73.) [43]. However, while medication treatment for 
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diabetes also significantly increased, there was no significant effect on glycosylated 
hemoglobin levels.
The ACA also mandates coverage of all US Preventive Services Task Force (USPSTF) A or 
B recommendations, without cost-sharing, by Medicare and all non-grandfathered 
commercial health plans [27]. Medicaid plans that are designed for groups targeted by new 
coverage expansions also must cover these services without cost-sharing. For traditional 
Medicaid populations, states can choose to cover these services without cost-sharing, and if 
they do so the federal government will pay the state for an additional 1 % of the cost of each 
service [44]. To the extent that health insurance and access to a usual source of care provide 
coverage for a minimum set of evidence-based preventive services, the ACA may improve 
the detection of prediabetes, as well as access to interventions to help prevent the 
development of type 2 diabetes. These two areas are described further below.
Source of Care
Insurance alone does not guarantee access to appropriate care. The identification, 
prevention, and management of highly prevalent chronic health states, including prediabetes 
and diabetes, require a primary care system with multidisciplinary, prepared, and proactive 
healthcare teams [45–48]. The ACA makes several strides towards strengthening primary 
care through its enhanced investment in federally qualified health centers (FQHCs) and 
health homes and its efforts to expand the primary care and community health workforces. 
Health homes (or patient-centered medical homes) are considered a quintessential 
component of successful population health management, combining delivery system 
innovations, self-management support, and technological interventions that have been linked 
to better diabetes care quality [49, 50] and preventive services [51]. Furthermore, the ACA 
encourages innovative forms of value-based payment designs to improve care coordination, 
as well as other approaches for population health management. To the extent that these 
innovations may encourage targeting and more proactive management of individuals at high 
risk for developing diabetes, they are discussed separately below, under Innovation and 
Enhanced Care Models.
Gaps
We were unable to find strong evidence linking ACA coverage expansions directly to 
improved access to diabetes prevention interventions or adoption of behaviors. Similarly, 
although there is a compelling rationale for how medical homes might promote health and 
prevent chronic disease, there has been little evidence to date demonstrating that these 
strategies will directly improve diabetes prevention.
It is also evident that the ACA has reduced the numbers of uninsured Americans, but many 
still live without health insurance or a medical home. Almost half of US states opted not to 
expand their Medicaid programs, leaving at least 4 million low-income American adults still 
without coverage for evidence-based preventive services [52]. In addition, access to health 
care may be a necessary step in clinical diabetes prevention but is not sufficient [53]. The 
ACA’s coverage expansions do not ensure that health delivery systems will provide the right 
care at the right time in an effective and efficient manner, including diabetes prevention 
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strategies. Since the ACA has not provided universal health insurance or medical home 
access, many high-risk Americans will still not receive essential preventive services, 
including prediabetes screening and evidence-based interventions through health insurance. 
It will be important not only to consider where current policy gaps exist but also to evaluate 
the impact of these and other existing policies on population-based diabetes prevention.
Awareness of Diabetes Risk
Currently, 9 in 10 Americans with prediabetes are unaware of their high risk status [54]. As 
such, lack of awareness of one’s risk or of the availability of interventions to reduce risk are 
barriers. ACA’s provisions for access to evidence-based preventive services are extremely 
helpful, but it is the nature of those recommended services that could specifically accelerate 
awareness of prediabetes and its management. In October 2015, the USPSTF issued a new 
“B” recommendation for screening for abnormal blood glucose in overweight or obese 
adults ages 40 to 70 [55]. This broad screening recommendation has the potential to identify 
greater numbers of people at high risk for developing type 2 diabetes, which opens the door 
for taking action to prevent the onset of diabetes.
One’s workplace can also serve as a channel for raising awareness, appraising health risks, 
and encouraging linkages to health care when appropriate. Given that the average working-
age American adult spends less than 1 to 2 hrs per year in a clinician’s office but almost 
2000 or more hours at work, the ACA also included provisions meant to equip CDC to 
provide financial and technical support for expanding well-ness programs, and to increase 
the incentives employers are allowed to offer employees for participation in those programs. 
To date, however, no details have been shared publicly about findings or best practices.
Gaps
One potential policy gap in raising awareness is that not all people with elevated risk for 
diabetes are included in the new USPSTF screening recommendation. For example, in the 
2009–2010 National Health and Nutrition Examination Survey, about 29 % of Americans 
ages 12 and older who had an A1c ≥5.7 % were not overweight or obese, and 26 % were 
less than age 45 [56]. These individuals would currently fall outside the target population of 
the USPSTF screening recommendation. Because adults of minority race or ethnicity are 
more likely to develop prediabetes or type 2 diabetes at younger ages and a leaner body 
mass [12], it is possible that the simple age- and body mass-driven screening 
recommendation could widen disparities in prediabetes detection.
Another potential gap is that neither health insurance coverage nor clinical practice 
recommendations are sufficient to ensure that screening and detection occur routinely [57]. 
Moreover, detection does not equal awareness. Additional action is needed to ensure that 
healthcare providers are prepared to communicate risk effectively, and to empower high risk 
patients to make informed decisions about prediabetes management. Large organizations 
such as the AMA, ADA, and joint efforts such as the National Diabetes Education Program 
provide tools and resources that can promote effective risk communication, action planning, 
and follow-up of high-risk patients [58, 59]. Unfortunately, there has been little research to 
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date on communication strategies that are most effective for empowering patients to take 
action.
A final gap is the challenge of enforcing the ACA’s preventive service coverage 
requirement. Prior analyses of health plan coverage policies for preventive services have 
suggested that no-cost preventive services have been adopted inconsistently or that health 
plan enrollees are often not made fully aware of the services covered [60*, 61]. A 2014 
Kaiser Family Foundation study also found that only 43 % of individuals were aware of the 
elimination of cost-sharing for preventive benefits under the ACA [62]. If coverage of 
recommended diabetes prevention services are to have a measurable impact, it will be 
important to evaluate implementation and explore how best to encourage or regulate 
consistent adoption of coverage policies.
Diabetes Prevention Interventions
Extensive research has shown that adults with prediabetes can prevent or delay the onset of 
diabetes through intensive lifestyle change and/or the use of select medications such as 
metformin [14–16]. Intensive lifestyle interventions focus on the support of modest weight 
reduction through dietary changes and increased physical activity. The ACA included 
multiple provisions to stimulate healthier lifestyle behaviors leading to diabetes prevention, 
as well as access to, availability, and participation in individual and group programs based 
upon the DPP.
The ACA created the Prevention and Public Health Fund (PPHF), which represents a 
substantial investment in prevention and public health programs with the goal of improving 
health and reducing costs (Table 1). The PPHF provides funding for the National Diabetes 
Prevention Program (NDPP), a public-private initiative that offers tools and resources at 
both a national and state level for bolstering community and workforce capacity to deliver 
DPP-based lifestyle interventions [63]. The NDPP includes a Diabetes Prevention 
Recognition Program (DPRP), promoting standards for DPP delivery, guidelines for 
organizational recognition, regional workforce trainings, and a national registry of 
recognized organizations offering the program [63]. As of October 2015, YMCA of the USA 
(YUSA), currently the largest volume intervention provider recognized by NDPP, reports 
having offered the YMCA’s Diabetes Prevention Program to 37,710 people, via 3320 trained 
lifestyle coaches in more than 1370 locations in 43 states [64]. The NDPP registry lists 587 
additional non-YMCA organizations delivering programs in all 50 states [63], representing 
tremendous growth in national capacity to reduce the burden of type 2 diabetes.
The ACA also enables access to NDPP-recognized programs through the aforementioned 
no-copay coverage requirements for preventive services. In August 2014, USPSTF issued a 
“B” recommendation that all overweight or obese adults with cardiovascular risk factors, 
including elevated blood glucose, be offered an intensive behavioral counseling intervention 
[55]. The USPSTF highlighted the DPP as a prototypical program that could be offered in 
either healthcare or community settings to satisfy this recommendation [65, 66]. If adopted 
by multiple health payers, such a provision could dramatically increase NDPP participation 
on a national scale.
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The PPHF also partially funds the National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), which sponsors two programs (DP13–1305 and DP14–
1421) that have provided enhanced funding to state and/or local health departments in all 50 
states and the District of Columbia for new PSE interventions targeting worksites, schools, 
communities, and health systems to prevent obesity, diabetes, heart disease, and stroke [67]. 
Under the Incentives for Prevention of Chronic Diseases in Medicaid Program, the ACA 
also legislated a funding program to enable states to test the effectiveness of providing 
incentives directly to Medicaid beneficiaries who participate in designated prevention 
programs and services. Several states, including Minnesota, Montana, Nevada, and New 
York, are focusing on diabetes prevention, specifically on increasing access to and 
enrollment in the NDPP [68].
Through these and additional initiatives summarized in Table 1, the ACA stimulated PSE at 
multiple levels to address diabetes prevention directly or indirectly via strategic programs 
targeting physical activity promotion and obesity prevention. As there has been very little 
reporting to date regarding the effectiveness of these initiatives, research is still needed to 
help understand how to improve these efforts, as well as to replicate and scale approaches 
that prove to be cost-effective.
Gaps
One challenge faced by many ACA provisions funded under the PPHF is the reduction or 
defunding of key programs. The ACA initially allocated the PPHF with $15 billion over the 
first 10 years, but in 2012 these funds were cut by $5 billion, and each year there have been 
additional debates about its funding. One repercussion of these cuts was termination of the 
Community Transformation Grant (CTG) program, which from 2011 to 2014 awarded $103 
million to 61 state and local governments, tribes and territories, and nonprofit organizations 
in 36 states to help communities reduce health gaps and prevent diabetes and other chronic 
conditions. Until there are strong evaluations demonstrating value of PSE initiatives such as 
the CTG, they likely will remain vulnerable to public funding cuts.
Similar to the USPSTF diabetes screening recommendation described above, enforcement 
will prove to be a challenge for the USPSTF-recommended intensive lifestyle interventions 
for adults with prediabetes. Under the ACA, this grade B recommendation must be offered 
with no copay. Because the cost of an intensive intervention (median cost of about $424 per 
person) [69] is more than the cost of blood glucose screening (national midpoint $17.87 per 
hemoglobin A1c test or $7.23 per plasma glucose test) [70], it is even more likely that health 
payers will look for lower-cost intervention alternatives or may offer more intensive NDPP 
interventions as an out-of-network service that includes higher levels of cost-sharing. Until 
strong evaluations demonstrate that the higher cost of more intensive programs yields greater 
health improvements over a relatively short time horizon (3 to 5 years), full coverage of full 
NDPP intervention programs may continue to present a challenge [20].
While national capacity to deliver DPP-based lifestyle interventions has increased 
dramatically, there still are not enough programs available to meet the population demand. 
Delivery of DPP-based interventions using broader channels, such as via television, internet, 
or smartphone, will also be helpful to ensure population reach and effectiveness [71]. One 
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encouraging step forward was the award of federal funding in 2012 to YUSA for a $12 
million demonstration project to implement and evaluate offering of the YMCA’s Diabetes 
Prevention Program to 10,000 Medicare beneficiaries in 17 communities across the nation 
[72]. This initiative will provide strong evidence and, if successful, could support a national 
Medicare coverage decision of DPP-based interventions.
Innovation and Enhanced Care Models
If the effects of healthcare-focused diabetes prevention efforts are to reach a population 
level, the preventive care continuum must become part of the fabric of healthcare delivery. 
The ACA includes several provisions to spark innovation and redesign in healthcare delivery 
and payment. For example, the Center for Medicare and Medicaid Innovation (CMMI) was 
created by the ACA to “test innovative payment and service delivery models…while… 
enhancing the quality of care.” [27] To date, CMMI has funded a portfolio of projects 
focused on innovations to prevent type 2 diabetes and other chronic diseases [73]. 
Accountable care organizations (ACOs) are a second way the ACA sought to spur 
innovation in the delivery and payment for health services. ACOs are networks of healthcare 
providers, hospitals, and other partners who share both medical and financial responsibility 
for a population of patients in hopes of improving quality and decreasing costs [74]. ACOs 
keep a share of any savings to the Medicare system resulting from high-quality care 
delivered below projected costs. These financial incentives drive ACOs to develop strategies 
for reducing expenditures without compromising healthcare access or quality. One important 
strategy is population health management, which involves proactive attempts to identify 
individuals at high risk for health deterioration and to intervene before their health declines. 
There is emerging evidence that ACOs may reduce healthcare expenditures, decrease acute 
care utilization, and increase patient satisfaction when compared to traditional fee-for-
service models [75]. To the extent that ACOs have strong incentives for preventing chronic 
diseases such as diabetes, these organizations may also help accelerate diabetes prevention 
by proactively identifying high-risk individuals and offering access to DPP-based 
interventions, before the development of type 2 diabetes.
Gaps
Despite the expansion of value-based funding models, only a handful of commercial payers 
have designed outcome-based payments for diabetes prevention services. One such approach 
involves a partnership between UnitedHealth Group (UHG) and YUSA, in which YMCAs 
receive increasing payments for health plan enrollees who achieve high YDPP attendance 
and/or ≥5 % weight loss. In 2013, UHG projected that (based on a cost of $400 per 
completer and mean participant weight loss of 5 %) health improvements could generate 
cost savings within 3 years [76]. A shift towards value-based payment models for diabetes 
prevention might be catalyzed by quality indicators for diabetes screening or for referral for 
evidence-based treatments. Such quality measures do not yet exist and, thus, should be 
considered an important area of new work for leading quality improvement organizations 
such as the National Committee for Quality Assurance and National Quality Forum [77, 78].
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Successful diabetes prevention will require a concerted effort by individuals, healthcare 
providers, and health systems to improve awareness of diabetes risk, linkages to effective 
interventions, and subsequent behavioral changes. The ACA provides many opportunities to 
support population-based diabetes prevention. Some immediate impacts have come in the 
form of (1) national increases in the number and availability of evidence-based lifestyle 
prevention programs and (2) requirements for health payer coverage of diabetes screening 
tests and lifestyle interventions, which could substantially increase risk awareness and 
engagement of high-risk persons in cost-effective programs. More policy actions are needed 
to expand the availability of DPP-based intervention programs, both in overall number and 
via a wider array of delivery channels, and to ensure that new USPSTF recommendations for 
prediabetes screening and lifestyle intervention services are offered routinely by healthcare 
providers and incorporated into transparent health payer coverage policies. Similarly, it will 
be important to conduct research that evaluates the impact of broader policy actions on 
diabetes prevention. One example is whether health delivery system and payment reforms 
designed to promote chronic disease prevention, care coordination, and population health 
management can have a specific impact on diabetes prevention. Another example involves 
efforts to raise public awareness about diabetes prevention, obesity, or its risk factors. For 
instance, the CDC, AMA, ADA, and the Ad Council recently announced a partnership to 
launch a first-of-its-kind PSA campaign encouraging individuals to know their risk for 
diabetes and make lifestyle changes [79]. On a broader scale, the First Lady’s “Let’s Move” 
initiative aims to raise public awareness and mobilize policy action across sectors to solve 
the problem of childhood obesity [80]. As this work continues to unfold, ongoing research 
of the impact of policies and programs on diabetes prevention will be needed to identify and 
preserve the most successful policies and to ensure that diabetes prevention reaches all 
segments of the American population equitably.
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The Diabetes Prevention Care Continuum. Policies, systems, and environmental changes are 
conceptualized as having the potential to influence diabetes prevention via beneficial 
behavioral changes that occur by two major pathways. The first pathway, depicted by the 
rectangle at the top of the figure, involves changes in the social, cultural, economic, or 
physical environment that function either to make healthy behaviors more accessible or 
desirable and unhealthy exposures more difficult or prohibited. The second pathway involves 
improvements in the functions or activities of health systems and the interfacing of those 
systems with public health agencies or community organizations to raise awareness and 
expand delivery of evidence-based diabetes prevention interventions. This second pathway, 
depicted in the middle of the figure with the large, solid arrows moving from left to right, is 
the primary focus of this review. The thin solid arrows indicate other forces, namely, the first 
pathway and innovation, which influences this second pathway. The dotted arrow represents 
the effect of the first pathway on the adoption of healthy behaviors at the individual level. 
See text for further description.
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Table 1
ACA provisions related to the Diabetes Prevention Care Continuum
ACA provision (section) Description
Access to health care
Insurance coverage Coverage improves access to diabetes preventive and
educational services offered by healthcare systems
Medicaid expansion (Section 2001) Medicaid eligibility expanded to all individuals with
income ≤138 % of the Federal Poverty Level beginning
1 January 2014. Not all states have elected to expand.
Creation of an Insurance Exchange
“Marketplace” (Section 1311)
Affordable choices of health benefit plans enhancing
access; the individual mandate for purchasing coverage
enables community rating of health insurance risks and
lower out-of-pocket expenditures for individuals.
Source of care Expanded focus on primary and preventive care creates
more opportunity for diabetes prevention.
Initiatives to expand the primary care
workforce (Sections 5301; 5501; 5503)
Higher reimbursements to primary care providers in health
professional shortage areas; expands medical residency
positions, enables grants to primary care training
programs; extends financial assistance to individuals
who intend to pursue a career in primary care
Initiatives to support delivery-system changes
to improve chronic disease prevention and
management (Sections 2703; 3502; 4101;
5208; 5601; 10503)
Provides states an option to enroll Medicaid beneficiaries
with 2 or more chronic conditions (including diabetes
and overweight) into a “Health Home” that receives
payment for a team-based approach to providing chronic
care services; expands funds for Federally Qualified
Health Centers, school-based health centers, and nurse-
managed health clinics offering health promotion/
disease prevention services; provides grants to establish
community-based interdisciplinary, inter-professional
“health teams” to support primary care practices;
ensures continuity of coverage
Awareness of diabetes risk
Clinical and community preventive services
(Section 4003)
Improves the coordination between USPSTF and the
Community Preventive Services Task Force; both have
now issued strong recommendations to offer intensive
lifestyle interventions to adults with prediabetes.
Education and outreach campaign regarding
preventive benefits (Section 4004)
Directs the Secretary to conduct a national prevention and
health promotion outreach and education campaign to
raise awareness of health promotion and disease
prevention activities
Expanded coverage for preventive health
services by commercial and public health
payers (Sections 2713; 4104; 4106)
Requires non-grandfathered commercial health plans,
Medicare, and Medicaid expansion program coverage of
USPSTF “A/B” recommendations for clinical
preventive services; also provides states additional
federal reimbursement (FMAP) for preventive services if
they elect to adopt under traditional Medicaid programs;
USPSTF has recommended prediabetes screening for
overweight/obese adults aged 40–70
Medicare coverage of annual wellness visit
(Section 4103)
Directs the reimbursement by Medicare for an annual
wellness visit focused on enacting a personalized
prevention plan for each beneficiary
Provisions to expand employer-based wellness
programs (Sections 2705; 4303; 10408)
Expands incentives and provides technical assistance to
employers to offer comprehensive wellness programs
that include but are not limited to health risk appraisal
and education (incentives for programs are listed under
interventions below)
Community Transformation and Healthy
Aging/Living Well Grants
(Sections 4201 & 4202)
Grants to health departments and community organizations
to provide education, raise awareness, and conduct
screenings across the full-age spectrum
Diabetes prevention interventions
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ACA provision (section) Description
Prevention and Public Health Fund (4002) Expands funds for the implementation and evaluation of
prevention and public health activities, including but not
limited to the National Diabetes Prevention Program and
Community Transformation Grants; partially funds
grants made by the National Center for Chronic Disease
Prevention and Health Promotion for state and local
public health initiatives to prevent and control diabetes,
heart disease, stroke, obesity, and other related risk
factors (see text for details)
National Diabetes Prevention Program (Section
10501)
Established a national program, coordinated by CDC, to
build workforce and programmatic capacity for
evidence-based diabetes prevention programs nationally
Essential Health Benefits Requirements
(Section 1302)
Requires commercial health plans to offer a package of
essential health benefits and limits cost-sharing; includes
preventive and wellness services and chronic disease
management
Expanded coverage for preventive health
services by commercial and public
health payers (Sections 2713; 4104; 4106)
Requires non-grandfathered commercial health plans,
Medicare, and Medicaid expansion program coverage of
USPSTF “A/B” recommendations for clinical
preventive services; also provides states additional
federal reimbursement for preventive services if they
elect to adopt under traditional Medicaid programs;
USPSTF has recommended intensive lifestyle
intervention services such as the Diabetes Prevention
Program for overweight/obese adults with prediabetes
Incentives for Prevention of Chronic Diseases
in Medicaid (Section 4108)
Provides grants to states to implement and evaluate a
program that provides incentives directly to Medicaid
beneficiaries with select chronic disease risk conditions
(including prediabetes) to participate in an evidence-
based prevention program or service consistent with
those recommended by the USPSTF or Community
Preventive Services Task Force
Community-based Prevention and Wellness
Programs for Medicare Beneficiaries
(Section 4202)
CDC grants to state or local health departments to carry out
5-year pilot programs including community
interventions, screenings, and, where appropriate,
clinical referrals for individuals between ages 55 and 64
Provisions to expand employer-based wellness
programs (Sections 2705; 4303; 10408)
Expands incentives and provides technical assistance to
employers to offer comprehensive wellness programs
and to extend participation incentives to a wide array of
employees with different health risks; extends funding to
implement and evaluate wellness programs
Nutrition Food Labeling Requirements
(Section 4205)
Requires chain restaurants and vending machine owners to
display nutrient composition information along with
recommended daily caloric intake information for
standard menu and food sale items
Innovation and enhanced care models
Establishment of Center for Medicare and
Medicaid Innovation (Section 3021)
Established to develop, evaluate, and expand innovative
payment and service delivery models; designed to
improve quality and reduce the cost of care; dedicated
funding is provided to allow for testing of models that
require benefits not currently covered by Medicare;
successful models can be expanded nationally; a large-
scale evaluation of offering community DPP
interventions to Medicare beneficiaries is underway
(see text)
Medicare Shared Savings Program
(Section 3022)
Rewards ACOs for reducing costs and improving quality of
care over time; should encourage population health
management activities that target individuals at high risk




Established the Institute to address questions most relevant
to patients; funds comparative clinical effectiveness
research with a goal of improving evidence available to
patients, providers, and other stakeholders involved in
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ACA provision (section) Description
making healthcare decisions
Research on optimizing the delivery
of public health services (Section 4301)
Funds public health services and systems research,
focusing on high-priority areas, including prevention, as
identified in the National Prevention Strategy or Healthy
People 2020
Provisions to ensure quality of care
(Section 2717)
Creation of reporting requirements for insurers regarding
efforts to improve health outcomes including care
coordination, chronic disease management, hospital
readmission prevention, wellness and health promotion,
and patient safety and quality improvement efforts
Quality measure development
(Sections 2701; 3013; 3014)
Authorized funding for the development and endorsement
of quality measures at AHRQ and CMS; directs the
Secretary of HHS to develop and report on a set of
quality measures for Medicaid eligible adults
Better Diabetes Care (Section 10407) Directs the preparation of a bi-annual national diabetes
report card and, if feasible, state diabetes report cards that
include outcomes for individuals with diabetes and
prediabetes; includes preventive care practices and
quality aggregate measures
Data pooled from the following resources: ACA [27], National Association of County and City Health Officials [81], Trust for America’s Health 
[82], Obamacare Facts [83]
ACA Patient Protection and Affordable Care Act, CMS Centers for Medicare and Medicaid Services, USPSTF United States Preventive Services 
Task Force, CDC Centers for Disease Control and Prevention, ACO Accountable Care Organization, AHRQ Agency for Healthcare Research and 
Quality, HHS United States Department of Health and Human Services
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